Arginine methyltransferases as regulators of RNA-binding protein activities in pathogenic Kinetoplastids by Campagnaro, Gustavo D et al.
This is a repository copy of Arginine methyltransferases as regulators of RNA-binding 
protein activities in pathogenic Kinetoplastids.




Campagnaro, Gustavo D, Nay, Edward, Plevin, Michael J orcid.org/0000-0003-2057-8291 
et al. (2 more authors) (2021) Arginine methyltransferases as regulators of RNA-binding 
protein activities in pathogenic Kinetoplastids. Frontiers in Molecular Biosciences. p. 





This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by White Rose Research Online
Arginine Methyltransferases as
Regulators of RNA-Binding Protein
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A large number of eukaryotic proteins are processed by single or combinatorial post-
translational covalent modifications that may alter their activity, interactions and fate. The
set of modifications of each protein may be considered a “regulatory code”. Among the
PTMs, arginine methylation, catalyzed by protein arginine methyltransferases (PRMTs),
can affect how a protein interacts with other macromolecules such as nucleic acids or
other proteins. In fact, many RNA-binding (RBPs) proteins are targets of PRMTs. The
methylation status of RBPs may affect the expression of their bound RNAs and impact a
diverse range of physiological and pathological cellular processes. Unlike most eukaryotes,
Kinetoplastids have overwhelmingly intronless genes that are arranged within polycistronic
units fromwhichmaturemRNAs are generated by trans-splicing. Gene expression in these
organisms is thus highly dependent on post-transcriptional control, and therefore on the
action of RBPs. These genetic features make trypanosomatids excellent models for the
study of post-transcriptional regulation of gene expression. The roles of PRMTs in
controlling the activity of RBPs in pathogenic kinetoplastids have now been studied for
close to 2 decades with important advances achieved in recent years. These include the
finding that about 10% of the Trypanosoma brucei proteome carries arginine methylation
and that arginine methylation controls Leishmania:host interaction. Herein, we review how
trypanosomatid PRMTs regulate the activity of RBPs, including by modulating interactions
with RNA and/or protein complex formation, and discuss how this impacts cellular and
biological processes. We further highlight unique structural features of trypanosomatid
PRMTs and how it contributes to their singular functionality.
Keywords: arginine methylation, PRMT, RNA-binding protein, Trypanosoma, Leishmania, gene expression,
Kinetoplastid, post-translational modification
INTRODUCTION
A large number of eukaryotic proteins are processed by single or combinatorial post-translational
modifications (PTMs) that may alter protein function, conformation, localization, and/or their
interaction with other macromolecules (Tak et al., 2019). The methylation of arginine residues is
mediated by Protein Arginine Methyltransferases (PRMTs), of which three types exist: I, II and III.
All three types generate ω-monomethylarginine (MMA) by transferring the methyl group from
S-adenosylmethionine (SAM) to a ω-nitrogen atom. Type I PRMTs can add a further methyl to the
same nitrogen to form asymmetric ω-dimethylarginine (aDMA) while type II PRMTs modify the
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other ω-nitrogen to generate symmetric ω-dimethylarginine
(sDMA) (Bedford, 2007) (Figure 1A). PRMTs show a
preference for arginine-glycine (RGG) rich motifs, which are
commonly enriched in intrinsically unstructured regions of
proteins and implicated in RNA binding and biomolecular
liquid-liquid phase separation (Chong et al., 2018).
Kinetoplastida are the only parasitic protozoa to harbor
genes encoding for PRMTs of types I, II and III (Fisk and Read,
2011) (Figure 1A). This group of early branching eukaryotes
includes the causative agents of important human diseases:
Sleeping Sickness (Trypanosoma brucei), Chagas disease
(Trypanosoma cruzi) and the leishmaniases (Leishmania
spp.). During their life cycles, trypanosomatids alternate
between several morphologically and metabolically different
stages, which requires fine-tuned regulation of gene
expression.
As part of the class Kinetoplastea, trypanosomatids display
some particular features, such as the arrangement of genes in long
polycistronic transcription units (PTUs) and trans-splicing of all
mRNAs (Adl et al., 2019). Given the lack of individual promoters
and terminators, virtually all genes in Kinetoplastids are
constitutively transcribed as part of PTUs (Clayton, 2016;
Damasceno et al., 2020), which makes these parasites good
models for the study of mechanisms involved in post-
transcriptional gene regulation.
A multitude of studies have shown that the levels of RNA-
binding proteins (RBPs) fluctuate throughout the life cycle of
trypanosomatids, some being stage-specific, even dictating the
transition from one biological form to another (Kolev et al., 2014;
de Pablos et al., 2019). Less, however, is understood about the
mechanisms regulating the activity of RBPs. In this sense,
arginine methylation has been gaining attention as a
regulatory mechanism of nucleic acid-binding protein activities
in trypanosomatids (Lott et al., 2013; Ferreira et al., 2020). In fact,
knowledge of trypanosomatid PRMTs has grown substantially in
the recent years, with the disclosure of protein structures, and the
FIGURE 1 | Molecular effects of arginine methylation in T. brucei and L. major. (A), Protein arginine methyltranferases (PRMTs) from types I, II and III are able to
generate monomethylarginine (MMA) by transfering the methyl group from S-adenosylmethionine to the terminal nitrogen atom of arginine residues. While type III PRMTs
only produce monomethylated products, type I PRMTs catalyze a second round of methylation at the same atom, generating asymmetrically dimethylated arginine
(aDMA), whereas type II PRMTs add another methyl group to the adjacent terminal nitrogen, forming symmetric dimethylarginine (sDMA). The inset table contains
the gene IDs of PRMT genes found in the genome of T. brucei and L. major. (B), Schematic representation of how methylation affects the capability of RBP16 to form
macromolecular complexes containing proteins (gray) and RNA (red line) in T. brucei. The RBP16 intrinsically disordered RGG domain is methylated by TbPRMT1 on
Arg78 and Arg85, whereas Arg93 is (potentially) methylated by either or both TbPRMT5 and TbPRMT7 (left). In its methylated state, RBP16 can associate with other
proteins (5S complex) or with proteins and RNA (11S complex). A non-methylatable version of RBP16 is still able to associate with RNA but loses the capability to form
multiprotein complexes. Non-methylated arginines are represented by gray circles and methylated arginines by red circles. (C), Representation of the methylation
mediated by L. majorPRMT7 on Alba3. Alba3 interacts with Alba1 and δ-amastin transcripts. Methylated Alba3 has a stronger association with δ-amastin transcripts and
protects the RNA from degradation. The ability of Alba3 to bind δ-amastin is reduced upon LmjPRMT7-knockout, which reduces the half-life of the transcripts from
approximately 4 h to around 1 h. *PRMT3 is currently known as PRMT1PRO in T. brucei; despite its similarity to mammalian PRMT3, TbPRMT3 misses key residues for
PRMT activity, and is rather a prozyme for the catalytic TbPRMT1, which was thus renamed to TbPRMT1ENZ.
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determination of the molecular effects of arginine methylation,
particularly on RBPs. The differences observed in the
biochemical, biophysical and structural properties of
trypanosomatid PRMTs in comparison to their mammalian
counterparts suggest that PRMTs may be good targets for
drug development.
Here, we provide an up-to-date review of the activities of
PRMTs in pathogenic trypanosomatids, as well as discuss the
effect of arginine methylation in cellular and molecular processes,
particularly on the function of RBPs. Moreover, we discuss the
structural features of trypanosomatid PRMTs and how these
might enable revised design and repurposing of current drugs




The first evidence for arginine methylation in T. brucei dates from
1991 (Yarlett et al., 1991), that was directly confirmed a decade
later (Pelletier et al., 2001). Recently, the use of high-throughput
techniques revealed that close to 10% of the T. brucei proteome
harbors methylated arginines (Lott et al., 2013), the product of the
cooperative action of five PRMTs found in its genome (Lott et al.,
2014). Nomenclature of Trypanosoma proteins corresponds to
the human PRMTs.
Trypanosoma brucei Protein Arginine
Methyltransferase 1, the First Discovered in
Kinetoplastids
The first T. brucei protein identified to harbor methylated
arginine residues was RBP16, a protein involved in
mitochondrial RNA processing (Hayman and Read, 1999;
Pelletier and Read, 2003). Three arginine residues, Arg-78,
Arg-85 and Arg-93, are part of the RGG domain of RBP16
and methylation influences RBP16-RNA interactions (Pelletier
et al., 2000; Miller and Read, 2003). Of these, only Arg-93 is
constitutively methylated, while methylation of Arg-78 or Arg-85
appears to be mutually exclusive.
In vitro methylation assays using recombinant RBP16 and T.
brucei procyclic whole cell protein extracts in the presence of
classic substrates of type I and type II PRMTs indicated RBP16 is
methylated by a trypanosome type I PRMT (Pelletier et al., 2001).
The search for the type I PRMT that methylates RBP16 led to the
identification of a protein 51% identical to the human PRMT1,
thus named TbPRMT1, whose knockdown (KD) abolished
RBP16Arg78 and RBP16Arg85 methylation (Pelletier et al., 2005;
Goulah et al., 2006). Arg-93 remains methylated, likely due to the
action of another PRMT. Curiously, TbPRMT1 is mostly present
in the cytoplasm, suggesting RBP16 might be methylated before
import into the mitochondrion (Fisk et al., 2010).
In T. brucei, RBP16 forms complexes of various sizes, but most
notably 5S and 11S complexes; the latter likely represents the
proteinaceous 5S complex bound to RNAs. Curiously, cells
depleted for TbPRMT1 or expressing the R78K, R85K and
R93K triple mutant RBP16 formed a 5S complex composed of
RBP16 bound only to mitochondrial guide RNAs (gRNAs),
implicit in RNA editing, but not mRNAs (Figure 1B).
Accordingly, non-methylatable RBP16 has an increased affinity
for gRNAs, yet displays lower affinity for mitochondrial
mRNAs (Goulah and Read, 2007). It is, however, unknown
which proteins interact with RBP16 and whether
mitochondrial mRNAs bind directly to RBP16 in the complex.
Nonetheless, expression of non-methylatable RBP16 has
been associated with destabilization of NADH dehydrogenase
subunit 4 mRNA, whose quantity is also lower in TbPRMT1-
KD cells, though TbPRMT1-knockdown also impacts levels
of other mRNAs (Goulah et al., 2006). The effects of arginine
methylation by TbPRMT1 are not limited to the mitochondrion.
DRBD18 is a cytoplasmic RBP whose methylation state leads
to different protein complex formation and alters mRNA
expression. RNAs stabilized by methylated DRBD18 are less
stable in the absence of TbPRMT1 or when non-methylatable
DRBD18 is expressed; the opposite is true for RNAs destabilized
by DRBD18 (Lott et al., 2015). In fact, TbPRMT1 knockout
has a broad, complex effect on mRNP associations, which
impacts cell metabolism, particularly energy production
pathways, as well as stress granule formation, and results in
reduced in vitro T. brucei growth and virulence in mice (Kafková
et al., 2018).
Trypanosoma brucei Protein Arginine
Methyltransferase 1 Activity Is Dependent
on TbPRMT3
Like TbPRMT1, TbPRMT3 was also identified as a potential type
I PRMT and knockdown of either TbPRMT1 or TbPRMT3
reduced aDMA levels in the cells. Interestingly, the reduction
in the protein level of either was accompanied by a reduction of
the other, suggesting an interdependent stability between
TbPRMT1 and TbPRMT3 (Pelletier et al., 2005; Lott et al., 2014).
However, TbPRMT3 is inactive in vitro (Kafková et al., 2017),
and its primary sequence lacks conserved residues in THW and
double E loops, which are typically well conserved and
responsible for substrate binding and positioning, respectively
(Tewary et al., 2019). Structural data showed that although
TbPRMT3 retains the four canonical PRMT domains
(N-terminus, SAM-binding Rossman fold domain,
dimerization arm and β-barrel domain; Figure 2A), it lacks a
crucial 310 α-helix in the Rossman fold, which alters the
dimerization interface and precludes SAM binding (Kafková
et al., 2017; Hashimoto et al., 2020). Importantly, T. cruzi
PRMT3 also lacks conserved THW and double E loops.
Functional studies have shown that TbPRMT3 is essential for
TbPRMT1 stability and activity, establishing it as a “prozyme” or
“pseudoenzyme” that supports the catalytically active TbPRMT1.
TbPRMT1 and TbPRMT3 have, thus, been renamed as
TbPRMT1ENZ and TbPRMT1PRO, respectively (Kafková et al.,
2017; Hashimoto et al., 2020) (Figure 1A). Interestingly, when
amino acids 41–52 were removed from TbPRMT1PRO,
methyltransferase activity was lost as the complex could no
longer bind substrates. Although enzymatically inactive,
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TbPRMT1PRO contributes to substrate recognition (Hashimoto
et al., 2020).
Unlike mammalian counterparts, TbPRMT1ENZ and
TbPRMT1PRO interact via a hydrophobic interface to form a
ring-like heterodimeric structure (Figure 2B), similar to
homodimeric PRMTs. Two TbPRMT1ENZ‒TbPRMT1PRO
heterodimers together form the functional heterotetramer
(Hashimoto et al., 2020). Curiously, TbPRMT1PRO can
homodimerize in solution, albeit minimally (Kafková et al.,
2017), whereas TbPRMT1ENZ is challenged to form
homodimers (Hashimoto et al., 2020), supporting structural
dependence on TbPRMT1PRO.
It is possible that TbPRMT1PRO (alone or as a homodimer)
performs moonlighting functions in the cell, as TbPRMT1PRO
transcripts were slightly increased upon DNA damage induction,
while TbPRMT1ENZ transcripts were reduced. TbPRMT1PRO has
also been shown to bind mRNA both in vitro and in vivo
independent of tetramer formation (Lueong et al., 2016; Stortz
et al., 2017; Kafková et al., 2018). The biological relevance of
proposed moonlighting properties remains unclear.
FIGURE 2 | The structural biology of T. brucei PRMTs. (A), Each of the five PRMT homologs in T. brucei contain the four canonical domains indicated. The SAM-
binding domain contains the residues that interact with a SAM molecule and the target arginine substrate. The β-barrel domain contains residues that interact with the
arginine substrate. The arm (dimerization arm) within the β-barrel domain interacts with another subunit via contacts to the SAM-binding domain. TbPRMTN-termini have
significant variability with elusive functional roles. Key conserved double E loop and THW loop are also indicated. B-D, The core dimeric interfaces of (B)
TbPRMT1ENZ-TbPRMT1PRO (PDB: 6DNZ) (C) TbPRMT6 (PDB: 4LWP) and (D) TbPRMT7 (PDB: 4M38). The surface structure represents the second subunit (or
TbPRMT1PRO indicated in B. The SAH and Arg peptides are indicated by pink-blue-red and cyan-blue-red sticks respectively. (E) The active site of TbPRMT7 (PDB:
4M38) as a representative. The SAHmolecule and arginine substrate are indicated. The double E loop (E172 and E181) and THW loop (Q329) residues interact with
the arginine substrate side chain. Dashed lines indicate hydrogen bonds. The combination of hydrogen bonds and electrostatic interactions from E172 and E181
with the arginine guanidino group result in strong salt bridges. Q329 forms a hydrogen bond to the guanidino group via its side chain amide oxygen.
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Trypanosoma brucei Protein Arginine
Methyltransferase 5
TbPRMT5 is the only type II PRMT expressed by the parasite, yet
the least studied T. brucei PRMT and the only one whose
structure remains unsolved. TbPRMT5 is by far the largest T.
brucei PRMT due to a very long N-terminal region, the biological
relevance of which is unknown (Figure 2A). In vitro,
recombinant TbPRMT5 displays a broad substrate specificity
that includes RBP16 (Pasternack et al., 2007). Whether
TbPRMT5 methylates RBP16 in vivo is unknown, but if so,
TbPRMT5 may be responsible for constitutive methylation of
RBP16Arg93. Moreover, the fact that recombinant TbPRMT5 is
active suggests that, unlike mammalian PRMT5, it does not
require a co-factor to function. Further to this, no homologues
of mammalian PRMT5 methylosome components were
identified in TbPRMT5 immunoprecipitation experiments
(Pasternack et al., 2007).
Under native conditions, TbPRMT5 is found in different
protein complexes, with sizes ranging between 150 and
700 kDa (Pasternack et al., 2007). Strikingly, TbPRMT5
interacts with Kinetoplastid-specific proteins, suggesting
importance in Kinetoplastid-specific pathways (Pasternack
et al., 2007). Further studies are necessary to verify TbPRMT5
substrates and determine consequences of PRMT5-dependent
methylation. In addition, sequence data indicates that the
currently uncharacterized Leishmania PRMT5 is much larger
(>1,000 amino acids) than its orthologues in humans and T.
brucei (637 and 784 amino acids, respectively) due to a much
longer N-terminus that contains no known conserved functional
domains. Elucidating the 3D structure of at least one
trypanosomatid PRMT5 will lend insight into potential
functional roles of this N-terminus.
Trypanosoma brucei Protein Arginine
Methyltransferase 6
TbPRMT6 is a type I PRMT that displays a narrow substrate
specificity. Accordingly, TbPRMT6 knockdown does not visibly
alter the cellular arginine methylation profile (Lott et al., 2014).
Results suggest that protein targets of TbPRMT6 methylation are
important for T. brucei cellular replication, given TbPRMT6-KD
caused a mild growth defect in vitro and led to the appearance of
aberrant cells (Fisk et al., 2010).
TbPRMT6 is expressed by both T. brucei procyclic and
bloodstream forms at equal levels and, despite being primarily
cytoplasmic, it interacts with several histones. TbPRMT6 also co-
purifies with proteins involved in nucleocytoplasmic transport
and RNA processing, indicating it might be important in
controlling nucleic acid metabolism and transport (Fisk et al.,
2010). Disruption of these processes is known to cause growth
defects in vitro and TbPRMT6 transcription is reduced in cells
exposed to DNA damage (Stortz et al., 2017).
TbPRMT6 contains the four canonical PRMT domains
(Figures 2A,C), and holds unique sequence and structural
features that appear conserved across the Kinetoplastids.
Secondary structure analysis of type I PRMTs indicates that
TbPRMT6 contains four insert regions and a truncated
C-terminus. The insertions seem to extend or introduce
additional α-helices (Wang et al., 2014b), indicating potential
relevance to methyltransferase activity and/or regulation, as well
as substrate selection. The exact role of these peculiarities is still to
be determined.
Importantly, the 3D structure of apo-TbPRMT6 complexed
with S-adenosylhomocysteine (SAH) revealed that substrate
binding remodels the active site to allow correct positioning of
the target arginine residue. These conformational changes involve
residues that are conserved in type I PRMTs, including His318 in
the THW loop and Glu142 in the Double E loop, suggesting this
feature may be conserved among type I enzymes (Wang et al.,
2014b).
Trypanosoma brucei Protein Arginine
Methyltransferase 7
Kinetoplastids are the only unicellular eukaryotes known to
express a PRMT7 homolog. Whereas the mammalian PRMT7
polypeptide contains two copies of the core PRMT fold, which
interact with each other to form an intramolecular- or pseudo-
dimer (Cura et al., 2014), TbPRMT7 contains only a single active
site and is almost half the size of human PRMT7, although much
more active (Fisk et al., 2009). TbPRMT7 is a cytoplasmic enzyme
expressed by both long-slender bloodstream and procyclic form
Trypanosoma brucei, and at least in the latter, it forms different
macromolecule complexes (Fisk et al., 2009, Fisk et al., 2010). The
composition of these complexes is still unknown, but it likely
contains RNA, as TbPRMT7 can bind RNA in vitro and in vivo
(Lueong et al., 2016; Kafková et al., 2018).
Curiously, knockdown of TbPRMT7 only minimally affects
the MMA profile, which might be due to an increase in the
monomethylation activity of other PRMTs (Lott et al., 2014).
Simultaneous knockdown of TbPRMT7 and TbPRMT1 reduced
bothMMA and aDMA levels in the cells, whereas the knockdown
of TbPRMT1 alone caused an accumulation of MMA. All
evidence suggests that TbPRMT7 generates monomethylated
substrates for other PRMTs and that TbPRMT1 activity can
compensate for reduction of TbPRMT7 activity (Lott et al.,
2014). Accordingly, recombinant TbPRMT7 displays broad
substrate specificity in vitro, which includes proteins known to
be methylated by TbPRMT1 and TbPRMT5, such as RBP16 and
TbRGG1 (Fisk et al., 2009). It is therefore possible that TbPRMT7
is also involved in RBP16Arg93 constitutive methylation.
The TbPRMT7 3D structure showed the expected four
canonical domains of PRMTs (Figures 2A,D). Similar to the
other Kinetoplastid PRMTs, homodimerization is facilitated by
hydrophobic interactions between a dimerization arm and the
SAM-binding domain of the other subunit (Wang et al., 2014a).
Extensive mutations on the dimerization arm abolished
dimerization, leaving only residual methyltransferase activity
(Debler et al., 2016).
Each TbPRMT7 monomer can bind SAM and arginine
substrate molecules (Wang et al., 2014a; Debler et al., 2016),
though the arginine substrate binding pocket appears to be
significantly narrower than those of type I and II PRMTs,
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consistent with its ‘monomethylation only’ profile. In fact,
conserved residues present in the double E and THW loops
restrict TbPRMT7 to monomethylation. An E181D mutant was
able to catalyze aDMA (Debler et al., 2016), while an E181D/
Q329A double mutant generated sDMA (Jain et al., 2016).
Simulation studies also indicate that E172 and Q329 are
crucial for proper substrate orientation and facilitating the
reaction mechanism (Thakur et al., 2019). Furthermore, a F71I
mutant was able to form dimethylated products (Jain et al., 2016;
Cáceres et al., 2018). These data showed the importance of the
double E loop with each of E172 and E181 forming two hydrogen
bonds to the guanidino group of the substrate arginine (Wang
et al., 2014a) (Figure 2E).
PROTEIN ARGININE
METHYLTRANSFERASE 7 IN LEISHMANIA
Although arginine methylation in Leishmania was observed prior
to identification in T. brucei (Paolantonacci et al., 1986), the
PRMT studies in Leishmania are much more limited, primarily
focused on Leishmania major PRMT7. Notably, different from
Trypanosoma PRMT3, Leishmania PRMT3 displays an intact
double E loop (although with mutated THW loop), and might be
enzymatically active, a matter for further investigation.
In contrast to T. brucei findings, LmjPRMT7-knockout clearly
changed the MMA profile in cells, although arginine
monomethylation was not abolished (Ferreira et al., 2014).
Interestingly, MMA seems less pronounced in the stationary
culture phase (containing metacyclic promastigotes), which
correlates with the absence of PRMT7 expression.
Furthermore, unlike mammalian PRMT7, LmjPRMT7 is a
cytoplasmic-specific enzyme. The observation that
mitochondrial LmjRBP16 became hypomethylated upon
LmjPRMT7-knockout suggests that some substrates are
modified before sorting to organelles (Ferreira et al., 2014;
Ferreira et al., 2020). Importantly, cytoplasmic LmjRBP16
displays a shorter half-life in the absence of LmjPRMT7,
indicating the importance of methylation for its stability
(Ferreira et al., 2020).
247 L. major proteins were found bearing MMA, of which 40
became hypomethylated and 17 became hypermethylated upon
LmjPRMT7 deletion (Ferreira et al., 2020). This suggests that at
least 40 proteins are LmjPRMT7 substrates and at least 17 display
alternative methylation upon LmjPRMT7 depletion. LmjPRMT7-
mediated MMA was enriched in RG/RGG motifs and “Nucleic
acid binding” and “RNA binding” were the most enriched
functions annotated for the hypomethylated proteins. Fifteen
out of the 40 hypomethylated proteins in LmjPRMT7-
knockout cells and 75 out of the 247 MMA-carrying proteins
were orthologues of L. mexicana candidate RBPs (de Pablos et al.,
2019; Ferreira et al., 2020).
AlthoughMMA often occur at variable proximity to the RNA-
binding domains, it can influence both RBP activity and RNA
fate. Absence of LmjPRMT7 reduces LmjAlba3:δ-amastinmRNA
binding, which caused a ∼4-fold decrease in the half-life of
δ-amastin transcripts (Ferreira et al., 2020) (Figure 1C).
Despite only minor changes in the global transcriptome of
LmjPRMT7-KO parasites, this mutation had a clear biological
impact as LmjPRMT7-KO cells are more virulent in vitro and in
vivo than wildtype L. major (Ferreira et al., 2014; Diniz et al.,
2021). Concordantly, the virulent L. major LV39 strain expressed
lower levels of LmjPRMT7 than the avirulent CC1 strain (Ferreira
et al., 2014) and knockout of LmjPRMT7 in the CC1 strain
recovered its virulence (Diniz et al., 2021). Curiously, gain of
virulence upon LmjPRMT7 deletion was not linked to an increase
in parasite burden, but to increased recruitment of neutrophils to
the site of infection (Diniz et al., 2021). Further studies will
investigate the biological process underlying this altered immune
response.
CONCLUDING REMARKS
Our knowledge on trypanosomatid RBPs is still very limited
(Clayton, 2013). Although recent high-throughput analyses have
expanded the list of actual and potential RBPs in these organisms
(Erben et al., 2014; Lueong et al., 2016; de Pablos et al., 2019),
many questions remain, particularly concerning how the protein:
RNA binding processes are coordinated throughout their
lifecycles (de Pablos et al., 2016). In this scenario, the function
of PRMTs in regulating post-transcriptional gene expression is of
great importance. It has been shown that Kinetoplastid PRMTs
interact with proteins from distinct cellular compartments and
that their function can impact different biological events, from
in vitro growth to animal infection. Interference with these
processes has been demonstrated to impact parasite fitness. In
addition, RBPs enriched in RG/RGG motifs are associated with
biomolecular phase separation (Chong et al., 2018). The
modification of RG motifs by PRMTs is a mechanism that
cells use to regulate formation and dissolution of biomolecular
condensates, a phenomenon that has not been widely explored in
Kinetoplastids and deserves more attention. Moreover,
investigating which other PTMs exist in close proximity to
methylated arginine residues and how these functionally
interact is of great interest.
The complex functions of Kinetoplastid PRMTs promote their
potential as candidate targets for drug or chemical probe
development. Although much structural, biochemical,
biophysical and inhibition data are still missing for the
Kinetoplastid proteins, the structural features known to be
specific to Trypanosomatid PRMTs combined with the large
inhibitor arsenal targeting human PRMTs may enable the
repurposing of drugs and the development of novel anti-
parasite strategies. Thus, improving our understanding of the
molecular and biological processes that coordinate and are
coordinated by PRMT activities in Kinetoplastids is of great
relevance for the treatment of diseases caused by these parasites.
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